A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy–induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial

Background. Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) are associated with bone loss leading to increased fracture rate among HIV-infected individuals. ART-induced bone loss is most intense within the first 48 weeks of therapy, providing a window for prophylaxis wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Ofotokun, Ighovwerha, Titanji, Kehmia, Lahiri, Cecile D., Vunnava, Aswani, Foster, Antonina, Sanford, Sara E., Sheth, Anandi N., Lennox, Jeffrey L., Knezevic, Andrea, Ward, Laura, Easley, Kirk A., Powers, Philip, Weitzmann, M. Neale
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
HIV/AIDS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4981757/
https://ncbi.nlm.nih.gov/pubmed/27193748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados